Dr. Emiloju is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511- Is this information wrong?
Education & Training
- University of IbadanClass of 2009
Certifications & Licensure
- GA State Medical License 2023 - 2025
- MN State Medical License 2021 - 2025
- PA State Medical License 2017 - 2022
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.Emiloju, O., Yin, J., Koubek, E., Reid, J., Borad, M., Lou, Y., Seetharam, M., Edelman, M., Sausville, E., Jiang, Y., Kaseb, A., Posey, J., Davis, S., Gores, G., Rober...> ;Investigational New Drugs. 2024 Feb 1
- Tumor-Informed Circulating Tumor DNA for Minimal Residual Disease Detection in the Management of Colorectal Cancer.Zemla, T., Mitchell, J., Mathis, K., McWilliams, R., Hubbard, J., Sinicrope, F., Shi, Q., Emiloju, O., Storandt, M., Tran, N., Jethwa, K., Mahipal, A., Thiels, C., Jin...> ;JCO Precision Oncology. 2024 Jan 1
- Selecting Optimal First-Line Treatment for Microsatellite Stable and Non-Mutated RAS/BRAF Metastatic Colorectal Cancer.Oluwadunni E Emiloju, Mojun Zhu, Hao Xie, Zhaohui Jin, Frank A Sinicrope, Joleen M Hubbard> ;Current Treatment Options in Oncology. 2023 Dec 1
- Join now to see all
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: